A growing body of evidence suggests that systemic inflammatory response (SIR) in the
tumor microenvironment is closely related to poor oncologic outcomes in cancer patients …

This work will review the metabolic information that various studies have obtained in recent
years on bladder cancer, with particular attention to discovering biomarkers in urine for the …

Background The systemic immune-inflammation index (SII) has been used as a prognostic
marker for several cancer types, but there is no in-depth study in bladder cancer. This study …

Although pretreatment neutrophil–lymphocyte ratio (NLR), lymphocyte–monocyte ratio
(LMR), and platelet–lymphocyte ratio (PLR) are reportedly associated with clinical outcomes …

Purpose: Inflammation-based prognostic scores including neutrophil-to-lymphocyte ratio
(NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) are …

Preliminary evidence suggests that a higher neutrophil–lymphocyte ratio (NLR) may be an
indicator of active ulcerative colitis (UC). However, it is not clear whether the NLR is a useful …

The objective of this study was to investigate the impact of neutrophil–lymphocyte ratio
(NLR) and the platelet–lymphocyte ratio (PLR) on the postoperative complication and long …

BACKGROUND Risk stratification is a major challenge in bladder cancer (BC), and a
biomarker is needed. Multiple studies have reported the neutrophil‐to‐lymphocyte ratio …

Background: We sought to determine which parsimonious combination of complete blood
count (CBC)-based biomarkers most efficiently predicts oncologic outcomes in patients …

The prognostic role of systemic inflammatory response (SIR) markers is unclear in patients
with non-muscle invasive bladder cancer (NMIBC). Here, we aimed to investigate the …